|

Long-term Follow-up Study of Patients Receiving CAR-T Cells

RECRUITINGSponsored by Medical College of Wisconsin
Actively Recruiting
SponsorMedical College of Wisconsin
Started2017-12-01
Est. completion2035-01-01
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT03375619

Summary

This protocol is designed as a long-term follow-up study of participants who will receive CAR-T cells as part of a clinical trial at the Medical College of Wisconsin/ Froedtert Hospital. The clinical trials include the following: Phase 1 Study of CAR-20/19-T Cells in Patients with Relapsed Refractory B Cell Malignancies (NCT03019055); Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma (NCT05976555); CAR20.19.22 T-cells in Relapsed, Refractory B-cell Malignancies (NCT05094206); LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies (NCT05990465); CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies (NCT04186520)

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* All participants who enrolled in a CAR-T study at Froedtert Hospital \& the Medical College of Wisconsin.

Exclusion Criteria:

* There are no exclusion criteria for this study.

Conditions10

Burkitt LymphomaCancerCentral Nervous System LymphomaChronic Lymphocytic LeukemiaDiffuse Large B-Cell LymphomaFollicular LymphomaLymphoma, Small LymphocyticLymphomas Non-Hodgkin's B-CellMantle Cell LymphomaMultiple Myeloma

Locations1 site

Froedtert Hospital & Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
Cancer Center Clinical Trials Office414-805-8900cccto@mcw.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.